Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis

Paller Amy S., Seyger Marieke M. B., Magariños Gabriel A., Pinter Andreas, Cather Jennifer C., Rodriguez-Capriles Claudia, Zhu Danting, Somani Najwa, Garrelts Alyssa, Papp Kim A., Kollaborációs szervezet: IXORA-PEDS Investigators, Kemény Lajos, et al
2022

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS) a 1-year, randomised, double-blinded, place...

Blauvelt Andrew, de Bruin-Weller Marjolein, Gooderham Melinda, Cather Jennifer C, Weisman Jamie, Pariser David, Simpson Eric L, Papp Kim A, Hong H Chih-Ho, Rubel Diana, Foley Peter, Prens Errol, Griffiths Christopher E M, Etoh Takafumi, Pinto Pedro Herranz, Pujol Ramon M, Szepietowski Jacek C, Ettler Karel, Kemény Lajos, Zhu Xiaoping, Akinlade Bolanle, Hultsch Thomas, Mastey Vera, Gadkari Abhijit, Eckert Laurent, Amin Nikhil, Graham Neil M H, Pirozzi Gianluca, Stahl Neil, Yancopoulos George D, Shumel Brad
2017